The new clinical domain concerns chimera sequences. Such synthetic entities integrate sections from different peptide families, allowing the development of novel therapeutic characteristics. The approach offers a https://chimerapeptides945111.thebegoodblog.com/834935/chimera-peptides-a-novel-therapeutic-frontier